“Self-amplifying” (more on what that means later) so-called vaccines are the hot new pharmaceutical commodity in the pipeline.
Indeed, as a matter of fact, these “self-amplifying” mRNA COVID shots are already on the market in Japan, ready to be deployed this winter, and likely headed to the United States in short order.
Related: Trump Self-Congratulates, Brags About COVID Vaccines AGAIN
Via Children's Health Defense (emphasis added):
Japan is offering a self-amplifying mRNA vaccine as one of the five routine COVID-19 vaccines available to the public for the 2024-2025 fall and winter seasons.
Japanese regulators approved the ARCT-154 shot in November 2023. According to a press release, ARCT-154 is the world’s first self-amplifying mRNA COVID-19 vaccine. Japan’s Ministry of Health, Labour and Welfare approved the vaccine for adults. It is jointly produced by the biotechnology firm CSL and Arcturus Therapeutics.
“The approval is based on positive clinical data from several ARCT-154 studies … which achieved higher immunogenicity results and a favorable safety profile compared to a standard mRNA COVID-19 vaccine comparator,” CSL said.
Japan’s vaccination program will offer the vaccines to people 65 and over, and 60- to 64-year-olds with severe underlying conditions, at a maximum cost of 7,000 yen (approximately $47). People not in these two categories can also receive the shots, but the fee will not be capped.
“Bully for Japan,” one might say. “What does this have to do with me?”
It turns out that, as Children’s Health Defense goes on to note, the Biden administration HHS back home has been quietly funding these same technologies to be eventually deployed on the unsuspecting American population.
Continuing:
In December 2023, the Biden administration announced agreements with CastleVax, Codagenix and Gritstone Bio to develop the first three vaccines under Project NextGen.
Operated by the Administration for Strategic Preparedness & Response under the U.S. Department of Health and Human Services (HHS), Project NextGen says it, “Accelerates and streamlines the rapid development of the next generation of vaccines and treatments through public-private collaborations.”*
According to investigative journalist Jon Fleetwood, one of the three companies awarded contracts, Gritstone Bio, has been developing a self-amplifying mRNA platform “for some time now.”
In September 2023, Gritstone Bio received a $433 million contract from HHS “to conduct a mid-stage study of its self-amplifying mRNA COVID-19 vaccine candidate.”
*Code for “public subsidization of private pharmaceutical corporations that will keep all the profit” — the free market at work! The government generously throws in lifetime immunity from lawsuits over injuries induced by their products for good measure.
Related: SHOCK Poll: A Quarter of Americans Say They Know Someone Personally Killed by COVID Jab
What makes these new “self-amplifying” shots potentially far deadlier than the conventional “safe and effective” mRNA tech?
The new tech contains the mRNA found in the original shots that triggers spike protein production, plus a newly added enzyme, RNA-dependent RNA polymerase (RdRp), that triggers additional mRNA production and accompanying proteins — a COVID shot “on steroids.”
Continuing:
Epidemiologist Nicolas Hulscher told The Defender, “These products are completely new. There is absolutely no long-term safety data on them.”…
Hulscher told The Defender that the risks associated with self-amplifying mRNA vaccines “are likely far greater than the risks of conventional mRNA injections.”
[Professor of microbiology Karina Acevedo] Whitehouse explained how self-amplifying mRNA injections are different than synthetic mRNA injections. Synthetic mRNA vaccines contain foreign mRNA that the body’s cells translate into a protein.
Self-amplifying mRNA injections also contain a foreign protein — but in addition, they contain an enzyme that instructs the body on how to make more mRNA.
Whitehouse said, “The function of this enzyme — RNA-dependent RNA polymerase (RdRp) — is to copy RNA,” which means that “once the cell produces the RdRp, it will make new copies of the foreign mRNA as well as more copies of its own instructions.” likening this function to that of a photocopier.
She likened the process to how a photocopier works. “It keeps going and going and going, making more copies that, in turn, help make more copies,” Whitehouse said.
